Eurocine Vaccines AB Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2023
For the nine months, revenue was SEK 0.005 million. Net loss was SEK 15.26 million compared to SEK 14.96 million a year ago.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.036 SEK | +2.86% | +7.14% | -21.74% |
1st Jan change | Capi. | |
---|---|---|
-21.74% | 893K | |
+34.14% | 51.12B | |
-6.54% | 39.4B | |
+34.92% | 38.48B | |
+12.62% | 26.36B | |
-12.11% | 26.22B | |
-13.43% | 20.96B | |
+43.73% | 14.02B | |
+31.81% | 12.49B | |
-4.54% | 11.61B |